Celyad Oncology (Public limited company)

Celyad
BE 0891.118.115 Active ●Rue Emile Francqui 6, 1435 Mont-Saint-Guibert

Celyad Oncology is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0891.118.115. It was founded on 24-07-2007. Its registered office is in Mont-Saint-Guibert. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 2 239 431 and a loss of € 564 911. These accounts report 10.5 full-time equivalents. Addrly gives it a financial health grade of D, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 3 financial years.

Information last updated on 07-10-2026.

Company information

Status
Active
Enterprise number
BE 0891.118.115
VAT registered
Yes
Founded
24-07-2007
Latest accounts
2025
Employees
10.5 FTE
Region
Wallonia
Establishments
1
Filing record
On time 3 of 3 years
Peppol e-invoicing
Registered
Registered office
Rue Emile Francqui 6, 1435 Mont-Saint-Guibert
Main activity
Scientific research and development
NACE activities
72101 Recherche-développement en biotechnologie
96999 Autres services personnels

Key figures of Celyad Oncology

202520242023
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -564 911+91 %€ -6 411 813+74 %€ -24 732 646
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 2 239 431+24 %€ 1 804 342-78 %€ 8 216 155
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 4 033 678-55 %€ 8 906 337-41 %€ 14 992 877
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
---
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
10.5-33 %15.6-20 %19.6

Financial estimate

Financial health grade D, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
15 mandates on record in the annual accounts. 2 of them started since 2024.
Create a free account

Similar companies

Other companies in the same activity in Mont-Saint-Guibert.

CompanyTown
Clinigen Clinical Supplies Management 1435 Mont-Saint-Guibert
TICUP 1435 Mont-Saint-Guibert
ERGOLABS GROUP 1435 Mont-Saint-Guibert
Ncardia Holding 1435 Mont-Saint-Guibert
Cellistic 1435 Mont-Saint-Guibert
IMMUNOVACC CONSULTING 1435 Mont-Saint-Guibert
Tools4Patient 1435 Mont-Saint-Guibert
NOVADIP BIOSCIENCES 1435 Mont-Saint-Guibert
Looking for more information about Celyad Oncology?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is Celyad Oncology still active? Yes. The Crossroads Bank for Enterprises lists Celyad Oncology as active.

What is the VAT number of Celyad Oncology? The VAT number of Celyad Oncology is BE 0891.118.115.

When was Celyad Oncology founded? Celyad Oncology was founded on 24-07-2007.

What is the address of Celyad Oncology? The current registered office of Celyad Oncology is Rue Emile Francqui 6, 1435 Mont-Saint-Guibert.

When did Celyad Oncology last file annual accounts? The latest annual accounts of Celyad Oncology were filed on 11-06-2026.

Does Celyad Oncology file its annual accounts on time? Yes. Celyad Oncology filed its annual accounts within the legal deadline for each of its last 3 financial years.

How many employees does Celyad Oncology have? Celyad Oncology employs 10.5 full-time equivalents according to its most recent annual accounts.

Is Celyad Oncology financially healthy? Addrly gives Celyad Oncology a financial health grade of D, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is Celyad Oncology profitable? The annual accounts of Celyad Oncology for 2025 show a loss of € 564 911.

What is the equity of Celyad Oncology? The equity of Celyad Oncology was € 2 239 431 at the close of the 2025 financial year.

Who are the directors of Celyad Oncology? The annual accounts of Celyad Oncology record 15 mandates. The names, roles and dates are visible with a free account.

Can Celyad Oncology receive Peppol e-invoices? Yes. Celyad Oncology is registered on the Peppol network and can receive structured electronic invoices.

What does Celyad Oncology do? The main activity of Celyad Oncology is: Scientific research and development.

Sources

How Addrly builds and refreshes this data